ISU Abxis Co (XKRX:086890) FCF Margin % : -54.57% (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is ISU Abxis Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ISU Abxis Co's Free Cash Flow for the three months ended in Mar. 2024 was ₩-9,010 Mil. ISU Abxis Co's Revenue for the three months ended in Mar. 2024 was ₩16,511 Mil. Therefore, ISU Abxis Co's FCF Margin % for the quarter that ended in Mar. 2024 was -54.57%.

As of today, ISU Abxis Co's current FCF Yield % is -8.41%.

The historical rank and industry rank for ISU Abxis Co's FCF Margin % or its related term are showing as below:

XKRX:086890' s FCF Margin % Range Over the Past 10 Years
Min: -192.71 Med: -48.34 Max: -24.2
Current: -30.72

During the past 13 years, the highest FCF Margin % of ISU Abxis Co was -24.20%. The lowest was -192.71%. And the median was -48.34%.

XKRX:086890's FCF Margin % is ranked better than
65.41% of 1038 companies
in the Biotechnology industry
Industry Median: -136.31 vs XKRX:086890: -30.72

ISU Abxis Co FCF Margin % Historical Data

The historical data trend for ISU Abxis Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ISU Abxis Co FCF Margin % Chart

ISU Abxis Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-94.47

-56.74

-27.11

-25.67

-24.20

ISU Abxis Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-36.59	-49.26	-43.08	22.29	-54.57

Competitive Comparison of ISU Abxis Co's FCF Margin %

For the Biotechnology subindustry, ISU Abxis Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ISU Abxis Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ISU Abxis Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ISU Abxis Co's FCF Margin % falls into.

ISU Abxis Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ISU Abxis Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-13141.827	/	54305.558
	=	-24.20 %

ISU Abxis Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-9009.848	/	16510.9
	=	-54.57 %

ISU Abxis Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of ISU Abxis Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

ISU Abxis Co (XKRX:086890) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ISU Abxis Co Ltd (XKRX:086890) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3Fl. Kookje Bldg., 90-1 Daeshin-dong, Seodaemun-gu,, Seoul, KOR, 120-160

Website

http://www.abxis.com

ISU Abxis Co.Ltd. is engaged in developing and manufacturing therapeutic antibodies in South Korea. It offers Abciximab, Clotinab, Abcertin, and Fabagal used to treat incurable diseases such as cancer and rare diseases.

ISU Abxis Co (XKRX:086890) Headlines

No Headlines